When was VI Biotherapeutics founded?

VI Biotherapeutics was founded in June 2024.

What is VI Biotherapeutics' primary sector?

VI Biotherapeutics operates in the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology.

What is the current employee count for VI Biotherapeutics?

VI Biotherapeutics has 1-10 employees.

What is the current product stage of VI Biotherapeutics?

VI Biotherapeutics is currently in the R&D product stage.

What is the most recent funding event for VI Biotherapeutics?

In January 2025, VI Biotherapeutics received a grant from the Israel Innovation Authority.

What was VI Biotherapeutics' first funding round?

VI Biotherapeutics secured a Seed round in June 2024.

What is VI Biotherapeutics' current funding stage?

VI Biotherapeutics is currently in the Seed funding stage.

VI Biotherapeutics

An Israeli startup in the health tech sector focused on AI-powered healthcare solutions.

Health Tech & Life Sciences

Stealth Mode

Seed Haniel, Israel Founded 2024

Last updated 2026-07-20

Total raised

—

Last: Undisclosed Round 2025-01

Stage

Seed

Founded

2024

Headcount

189

Haniel, Israel

Sector

Health Tech & Life Sciences

Website ↗Registrar ID: 517002846 (VI BIOTHERAPEUTICS LTD)

About

VI Biotherapeutics is an Israeli health tech startup that leverages AI to develop healthcare solutions. They focus on optimizing trial recruitment, activating patients and providers, and streamlining operations for biopharma companies. The company aims to maximize member health outcomes and financial returns for health organizations. The company has stated it supports over 190 million patients and members, has helped bring over 50 drugs to market, and has generated more than $2 billion in measurable value for its clients.

Headcount over time

189 employees (2026-09) · 1 point

Offices

Haniel, Israel · HQ / main office

Q&A

When was VI Biotherapeutics founded?: VI Biotherapeutics was founded in June 2024.
What is VI Biotherapeutics' primary sector?: VI Biotherapeutics operates in the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology.
What is the current employee count for VI Biotherapeutics?: VI Biotherapeutics has 1-10 employees.
What is the current product stage of VI Biotherapeutics?: VI Biotherapeutics is currently in the R&D product stage.
What is the most recent funding event for VI Biotherapeutics?: In January 2025, VI Biotherapeutics received a grant from the Israel Innovation Authority.
What was VI Biotherapeutics' first funding round?: VI Biotherapeutics secured a Seed round in June 2024.
What is VI Biotherapeutics' current funding stage?: VI Biotherapeutics is currently in the Seed funding stage.

Team · 2

Omri Yoffe

Founder · CEO & Co-Founder

Zvika Orron

Founder · CTO & Co-Founder

External links

Website	vi.co

Identifiers & details

Legal name	VI BIOTHERAPEUTICS LTD
Founded	2024-6
Employees (exact)	189

Radar intelligence

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)	517002846
Status	פעילה
Corp type	ישראלית חברה פרטית
Incorporated	2024-06-25
Purpose	לעסוק בכל עיסוק חוקי
Liability	מוגבלת
In violation (unfiled)	no
Active charges / liens	0
Registry events	0
Registered address	הראשונים 35 חניאל